CLAFORAN
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CEFOTAXIME AS SODIUM 1 G
Available from:
SANOFI - AVENTIS ISRAEL LTD
ATC code:
J01DD01
Pharmaceutical form:
POWDER FOR SOLUTION FOR INJ/INF
Administration route:
I.M, I.V
Manufactured by:
PATHEON UK LIMITED, UK
Therapeutic group:
CEFOTAXIME
Therapeutic indications:
Severe infections caused by cefotaxime - sensitive pathogens : Infections of the respiratory tract of the kidneys and urinary tract of the skin and soft tissues of the bones and joints of the genital organs including gonorrhoea and of the abdominal region. Sepsis endocarditis meningitis. For preoperative prophylaxis in patients who are at increased risk from infection. For the prophylaxis of infections in patients with reduced resistance.
Authorization date:
2012-11-01
